Electronic device on trial for osteoporosis treatment
This article was originally published in Clinica
Executive Summary
The FDA has approved a clinical trial by researchers at the National Osteoporosis Institute (NOI) in Long Island, New York, of a bone growth stimulator for treating osteoporois is designed as a chair pad on which the patient sits for several hours a day. The device, developed by Orthofix International, is based on the company's pulsed electromagnetic field (PEMF) technology, used in a variety of its bone growth stimulators, including Spinal-Stim Lite and Physio-Stim Lite.